PL2628733T3 - Pochodna acylobenzenu - Google Patents

Pochodna acylobenzenu

Info

Publication number: PL2628733T3
Authority: PL; Poland
Prior art keywords: acylbenzene; derivative; acylbenzene derivative
Prior art date: 2010-10-14

Application number

PL11832583T

Other languages

English (en)

Inventor

Shigeo Yamanoi

Takahiro Katagiri

Hidenori Namiki

Madoka Hatta

Koji Matsumoto

Kanako Takahashi

Tomomi Yoshitomi

Yuichi Ochiai

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-10-14

Filing date

2011-10-13

Publication date

2015-05-29

2011-10-13 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2015-05-29 Publication of PL2628733T3 publication Critical patent/PL2628733T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL11832583T 2010-10-14 2011-10-13 Pochodna acylobenzenu PL2628733T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2010231471		2010-10-14
JP2011022325		2011-02-04
PCT/JP2011/073489 WO2012050151A1 (ja)	2010-10-14	2011-10-13	アシルベンゼン誘導体
EP11832583.6A EP2628733B1 (en)	2010-10-14	2011-10-13	Acylbenzene derivative

Publications (1)

Publication Number	Publication Date
PL2628733T3 true PL2628733T3 (pl)	2015-05-29

Family

ID=45938375

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11832583T PL2628733T3 (pl)	2010-10-14	2011-10-13	Pochodna acylobenzenu

Country Status (27)

Country	Link
US (1)	US8722711B2 (pl)
EP (1)	EP2628733B1 (pl)
JP (2)	JP5069813B2 (pl)
KR (1)	KR101829086B1 (pl)
CN (1)	CN103249726B (pl)
AU (1)	AU2011314712B2 (pl)
BR (1)	BR112013009043B8 (pl)
CA (1)	CA2814628C (pl)
CO (1)	CO6771403A2 (pl)
CY (1)	CY1116303T1 (pl)
DK (1)	DK2628733T3 (pl)
ES (1)	ES2532706T3 (pl)
HR (1)	HRP20150225T1 (pl)
IL (1)	IL225724A (pl)
MX (1)	MX2013004176A (pl)
MY (1)	MY160300A (pl)
NZ (1)	NZ610145A (pl)
PH (1)	PH12013500711A1 (pl)
PL (1)	PL2628733T3 (pl)
PT (1)	PT2628733E (pl)
RS (1)	RS53965B1 (pl)
RU (1)	RU2585765C2 (pl)
SG (1)	SG189320A1 (pl)
SI (1)	SI2628733T1 (pl)
SM (1)	SMT201500067B (pl)
TW (1)	TWI487699B (pl)
WO (1)	WO2012050151A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2012291150A1 (en)	2011-07-29	2014-02-20	Daiichi Sankyo Company, Limited	N-hetero-ring-substituted amide derivative
EP3009433B1 (en)	2012-01-18	2017-06-21	Daiichi Sankyo Company, Limited	2-phenyl-1,3-oxazole and 5-phenyl-1,2,4-oxadiazole derivatives for the treatment of diabetes
JP2017119628A (ja) *	2014-05-09	2017-07-06	日産化学工業株式会社	置換アゾール化合物及び糖尿病治療薬
WO2017104782A1 (ja) *	2015-12-17	2017-06-22	第一三共株式会社	オキサジアゾール化合物の製造方法
TW201731506A (zh) *	2016-01-19	2017-09-16	第一三共股份有限公司	糖尿病治療劑之倂用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4401108A1 (de) *	1994-01-17	1995-07-20	Bayer Ag	1,2,4-Oxadiazol-Derivate
TR200100352T2 (tr) *	1997-10-06	2001-06-21	Eli Lilly And Company	Nöro-koruyucu maddeler olarak yararlı yeni bileşikler
WO2002016332A1 (en) *	2000-08-23	2002-02-28	Eli Lilly And Company	Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
GB0029974D0 (en) *	2000-12-08	2001-01-24	Glaxo Group Ltd	Chemical compounds
GB0303503D0 (en) *	2003-02-14	2003-03-19	Novartis Ag	Organic compounds
CN1898235A (zh)	2003-12-24	2007-01-17	普罗西迪恩有限公司	作为gpcr受体激动剂的杂环衍生物
EP2308840A1 (en)	2005-06-30	2011-04-13	Prosidion Limited	GPCR agonists
GB0513257D0 (en) *	2005-06-30	2005-08-03	Prosidion Ltd	Compounds
JP5114395B2 (ja) *	2005-06-30	2013-01-09	プロシディオン・リミテッド	Ｇｐｃｒアゴニスト
JPWO2007013694A1 (ja) *	2005-07-29	2009-02-12	武田薬品工業株式会社	フェノキシアルカン酸化合物
KR20080109075A (ko)	2006-04-06	2008-12-16	프로시디온 리미티드	헤테로사이클릭 ｇｐｃｒ 작용제
EP2241558A1 (en) *	2009-04-03	2010-10-20	Merck Serono SA	Oxadiazole derivatives
ES2459950T3 (es)	2009-08-05	2014-05-13	Daiichi Sankyo Company, Limited	4-(1,2,4-dioxazol-3-il)benzamidas para el tratamiento de la diabetes y la obesidad
WO2011016470A1 (ja)	2009-08-05	2011-02-10	第一三共株式会社	スルホン誘導体
GB201006166D0 (en) *	2010-04-14	2010-05-26	Prosidion Ltd	Compounds for the treatment of metabolic disorders

2011
- 2011-10-13 MX MX2013004176A patent/MX2013004176A/es active IP Right Grant
- 2011-10-13 US US13/879,076 patent/US8722711B2/en active Active
- 2011-10-13 MY MYPI2013001311A patent/MY160300A/en unknown
- 2011-10-13 CN CN201180059656.5A patent/CN103249726B/zh not_active Expired - Fee Related
- 2011-10-13 ES ES11832583.6T patent/ES2532706T3/es active Active
- 2011-10-13 RS RS20150151A patent/RS53965B1/sr unknown
- 2011-10-13 BR BR112013009043A patent/BR112013009043B8/pt not_active IP Right Cessation
- 2011-10-13 HR HRP20150225TT patent/HRP20150225T1/hr unknown
- 2011-10-13 PL PL11832583T patent/PL2628733T3/pl unknown
- 2011-10-13 JP JP2012527924A patent/JP5069813B2/ja not_active Expired - Fee Related
- 2011-10-13 PH PH1/2013/500711A patent/PH12013500711A1/en unknown
- 2011-10-13 DK DK11832583T patent/DK2628733T3/en active
- 2011-10-13 RU RU2013121816/04A patent/RU2585765C2/ru not_active IP Right Cessation
- 2011-10-13 TW TW100137080A patent/TWI487699B/zh not_active IP Right Cessation
- 2011-10-13 PT PT11832583T patent/PT2628733E/pt unknown
- 2011-10-13 NZ NZ610145A patent/NZ610145A/en not_active IP Right Cessation
- 2011-10-13 AU AU2011314712A patent/AU2011314712B2/en not_active Ceased
- 2011-10-13 CA CA2814628A patent/CA2814628C/en not_active Expired - Fee Related
- 2011-10-13 EP EP11832583.6A patent/EP2628733B1/en active Active
- 2011-10-13 SI SI201130404T patent/SI2628733T1/sl unknown
- 2011-10-13 KR KR1020137009191A patent/KR101829086B1/ko not_active Expired - Fee Related
- 2011-10-13 SG SG2013026281A patent/SG189320A1/en unknown
- 2011-10-13 WO PCT/JP2011/073489 patent/WO2012050151A1/ja not_active Ceased
2012
- 2012-08-17 JP JP2012180891A patent/JP5869985B2/ja not_active Expired - Fee Related
2013
- 2013-04-11 IL IL225724A patent/IL225724A/en active IP Right Grant
- 2013-05-10 CO CO13117693A patent/CO6771403A2/es not_active Application Discontinuation
2015
- 2015-02-20 CY CY20151100181T patent/CY1116303T1/el unknown
- 2015-03-18 SM SM201500067T patent/SMT201500067B/xx unknown

Also Published As

Publication number	Publication date
SG189320A1 (en)	2013-05-31
EP2628733A1 (en)	2013-08-21
IL225724A0 (en)	2013-06-27
PT2628733E (pt)	2015-03-24
TWI487699B (zh)	2015-06-11
BR112013009043B8 (pt)	2019-09-17
CN103249726A (zh)	2013-08-14
JPWO2012050151A1 (ja)	2014-02-24
US8722711B2 (en)	2014-05-13
EP2628733A4 (en)	2014-02-26
MX2013004176A (es)	2013-10-25
RU2013121816A (ru)	2014-11-20
CA2814628C (en)	2015-06-16
AU2011314712A1 (en)	2013-05-02
AU2011314712B2 (en)	2016-05-26
RS53965B1 (sr)	2015-08-31
SI2628733T1 (sl)	2015-10-30
JP5069813B2 (ja)	2012-11-07
CY1116303T1 (el)	2017-02-08
HK1185082A1 (en)	2014-02-07
BR112013009043B1 (pt)	2019-06-18
SMT201500067B (it)	2015-05-05
JP2012224640A (ja)	2012-11-15
ES2532706T3 (es)	2015-03-31
EP2628733B1 (en)	2014-12-24
CA2814628A1 (en)	2012-04-19
KR101829086B1 (ko)	2018-02-13
CO6771403A2 (es)	2013-10-15
CN103249726B (zh)	2015-01-07
KR20130099094A (ko)	2013-09-05
NZ610145A (en)	2015-02-27
WO2012050151A1 (ja)	2012-04-19
PH12013500711A1 (en)	2015-11-06
JP5869985B2 (ja)	2016-02-24
DK2628733T3 (en)	2015-03-30
TW201305121A (zh)	2013-02-01
IL225724A (en)	2015-10-29
MY160300A (en)	2017-02-28
RU2585765C2 (ru)	2016-06-10
BR112013009043A2 (pt)	2016-07-26
HRP20150225T1 (hr)	2015-06-19
US20130217733A1 (en)	2013-08-22

Publication	Publication Date	Title
AP3607A (en)	2016-02-26	Substituted imidazopyridazines
AP3107A (en)	2015-01-31	5-Alkynyl-pyrimidines
IL222646A0 (en)	2012-12-31	N3-substituted -n1-sulfonyl-5-fluoropyrimidinone derivatives
SI2534132T1 (sl)	2017-08-31	Substituirani pirolidin-2-karboksamidi
ZA201300032B (en)	2013-09-25	Tetrahydrocarboline derivative
ZA201209117B (en)	2013-09-25	Tetrahydro-pyrido-pyrimidine derivatives
ZA201304430B (en)	2014-12-23	Substituted sodium-1h-pyrazole-5-olate
GB2490849B (en)	2020-01-01	Di-aspirin derivatives
ZA201303887B (en)	2014-03-26	2-carboxamide-4-piperazinyl-benzofuran derivative
PT2628733E (pt)	2015-03-24	Derivado de acilbenzeno
HUP1000243A2 (en)	2012-01-30	8-hidroxy-quinoline derivatives
PT2634171E (pt)	2015-09-16	Derivado de 23-ino-vitamina d3
ZA201209248B (en)	2013-08-28	Amido-tropane derivatives
IL220983A0 (en)	2012-09-24	2-aldoximino-5-fluoropyrimidine derivatives